Hansa Biopharma Files Confidential Draft for Potential US IPO

MT Newswires Live15:26

Hansa Biopharma (HNSA) said Friday it confidentially submitted a draft registration statement to the US Securities and Exchange Commission for a potential initial public offering of American depositary shares in the US.

The company said it also plans a potential concurrent private placement of ordinary shares in Europe.

Hansa intends to list the ADSs on the Nasdaq under the symbol 'HNSA' while maintaining its existing Nasdaq Stockholm listing, the company said.

Hansa Biopharma said the size, timing and price range of the offering have not been determined, and the IPO remains subject to regulatory review, market conditions and investor demand.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2661250272?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 15:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661250272","market":"hk","top_or_hot":-1,"title":"Hansa Biopharma Files Confidential Draft for Potential US IPO","media":"MT Newswires Live","content":"<html><body><p> Hansa Biopharma (HNSA) said Friday it confidentially submitted a draft registration statement to the US Securities and Exchange Commission for a potential initial public offering of American depositary shares in the US.</p><p>The company said it also plans a potential concurrent private placement of ordinary shares in Europe.</p><p>Hansa intends to list the ADSs on the Nasdaq under the symbol 'HNSA' while maintaining its existing Nasdaq Stockholm listing, the company said.</p><p>Hansa Biopharma said the size, timing and price range of the offering have not been determined, and the IPO remains subject to regulatory review, market conditions and investor demand.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hansa Biopharma Files Confidential Draft for Potential US IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHansa Biopharma Files Confidential Draft for Potential US IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-21 15:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hansa Biopharma (HNSA) said Friday it confidentially submitted a draft registration statement to the US Securities and Exchange Commission for a potential initial public offering of American depositary shares in the US.</p><p>The company said it also plans a potential concurrent private placement of ordinary shares in Europe.</p><p>Hansa intends to list the ADSs on the Nasdaq under the symbol 'HNSA' while maintaining its existing Nasdaq Stockholm listing, the company said.</p><p>Hansa Biopharma said the size, timing and price range of the offering have not been determined, and the IPO remains subject to regulatory review, market conditions and investor demand.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KCE","symbol_name":"SPDR KBW Capital Markets ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661250272","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661250272","pubTimestamp":1787297172,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hansa Biopharma  said Friday it confidentially submitted a draft registration statement to the US Securities and Exchange Commission for a potential initial public offering of American depositary shares in the US.The company said it also plans a potential concurrent private placement of ordinary shares in Europe.Hansa intends to list the ADSs on the Nasdaq under the symbol 'HNSA' while maintaining its existing Nasdaq Stockholm listing, the company said.Hansa Biopharma said the size, timing and price range of the offering have not been determined, and the IPO remains subject to regulatory review, market conditions and investor demand.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"KCE":"SPDR KBW Capital Markets ETF","FRHC":"Euronext CAC Health Care","IPOS":"Renaissance International IPO ETF","BK4127":"投资银行业与经纪业","REDS":"RPM Republican Senate ETF"},"translate_title":"Hansa Biopharma 提交潜在美国 IPO 的机密草案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REDS":1.5,"FRHC":1.5,"KCE":1.5,"IPOS":1.5},"content_text":"Hansa Biopharma (HNSA) said Friday it confidentially submitted a draft registration statement to the US Securities and Exchange Commission for a potential initial public offering of American depositary shares in the US.The company said it also plans a potential concurrent private placement of ordinary shares in Europe.Hansa intends to list the ADSs on the Nasdaq under the symbol 'HNSA' while maintaining its existing Nasdaq Stockholm listing, the company said.Hansa Biopharma said the size, timing and price range of the offering have not been determined, and the IPO remains subject to regulatory review, market conditions and investor demand.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2661250272","isCrawlerRequest":true}